Background The cardioprotective ability of n-3 polyunsaturated fatty acids (PUFAs) is
controversial. Most studies suggest a specific role for PUFAs in cardioprotection from …

We aimed to investigate the causal effects of n-3 and n-6 polyunsaturated fatty acids
(PUFAs) on the risk of coronary artery disease (CAD) through Mendelian randomization …

Background The role of n-6 polyunsaturated fatty acids (PUFAs) in ischemic heart disease
(IHD) is controversial, and dietary guidelines vary. Observationally, lower saturated fat intake …

Long-chain n-3 polyunsaturated fatty acid (PUFA) supplementation has shown potential
benefits in the prevention of coronary heart disease (CHD); however, the impact of omega-3 …

Background Despite early interest in the health effects of polyunsaturated fatty acids (PUFA),
there is still substantial controversy and uncertainty on the evidence linking PUFA to …

Background This study was to explore the association between dietary polyunsaturated fatty
acids (PUFAs) consumption and cardiovascular diseases (CVDs), all-cause mortality, and …

Poly unsaturated fatty acids (PUFAs) have usually been associated with beneficial health
effects on early life and later life disease such as cardiovascular diseases (CVD). Emerging …

Background—Although omega-6 polyunsaturated fatty acids (n-6 PUFA) have been
recommended to reduce coronary heart disease (CHD), controversy remains about benefits …

Today, there are several observational and experimental studies, especially clinical
randomized trials, that have proven the beneficial effects of n-3 polyunsaturated fatty acids …

Background—Consumption of polyunsaturated fatty acids (PUFAs) may reduce coronary
heart disease (CHD) risk, but n-6 PUFAs may compete with n-3 PUFA metabolism and …